Healthcare & Life Sciences
Biocross
Spain
alivepre-seed
pre-seed
Stage
1
Investors
About
Biocross develops blood-based biomarkers for the early diagnosis of Alzheimer's disease, with its first product being an APOE4 genetic risk test.
Explore Biocross's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.